MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Oncomed Pharmaceuticals Company Profile (NASDAQ:OMED)

Consensus Ratings for Oncomed Pharmaceuticals (NASDAQ:OMED) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $35.50 (57.78% upside)

Analysts' Ratings History for Oncomed Pharmaceuticals (NASDAQ:OMED)
Show:
DateFirmActionRatingPrice TargetActions
6/2/2015Piper JaffraySet Price TargetBuy$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015BMO Capital MarketsSet Price TargetBuy$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2014BMO Capital MarketsReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2014JMP SecuritiesInitiated CoverageOutperform$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2014Jefferies GroupInitiated CoverageMarket Outperform$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2014BMO Capital MarketsReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2014MizuhoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014Jefferies GroupLower Price Target$50.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2014MizuhoInitiated CoverageBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/17/2014Piper JaffrayBoost Price Target$48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2013Jefferies GroupBoost Price TargetBuy$27.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2013BMO Capital MarketsInitiated CoverageOutperform$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2013Leerink SwannInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2013Piper JaffrayInitiated CoverageOverweight$30.00 -> $19.84View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2013Jefferies GroupInitiated CoverageBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2013 forward)